J Stroke.  2020 May;22(2):225-233. 10.5853/jos.2019.02908.

Perfusion Imaging to Select Patients with Large Ischemic Core for Mechanical Thrombectomy

Affiliations
  • 1Diagnostic and Therapeutic Neuroradiology, CHRU de Tours, Tours, France
  • 2Department of Interventional Neuroradiology, University Hospital Center of Montpellier, Gui de Chauliac Hospital, Montpellier, France
  • 3Centre Hospitalier Sainte Anne, Neuroradiology Department, Paris University, INSERM U1266, Psychiatry and Neurosciences Institute of Paris, Paris, France
  • 4University Hospital of Nancy, Department of Diagnostic and Therapeutic Neuroradiology, INSERM U1254, Nancy, France
  • 5Department of Diagnostic and Interventional Neuroradiology, Timone Hospital, Aix Marseille University, Marseille, France
  • 6Neurology Department, Timone Hospital, Aix Marseille University, Marseille, France
  • 7Department of Diagnostic and Interventional Neuroradiology, Guillaume et René Laennec University Hospital, Nantes, France
  • 8Department of Interventional Neuroradiology, Dupuytren University Hospital, Limoges, France
  • 9Department of Diagnostic and Interventional Neuroradiology, Pellegrin Hospital-University Hospital of Bordeaux, Bordeaux, France
  • 10Institute of Diagnostic, Interventional and Pediatric Radiology and Institute of Diagnostic and Interventional Neuroradiology, University Hospital Bern, Inselspital, University of Bern, Bern, Switzerland

Abstract

Background and Purpose
Patients with acute ischemic stroke, proximal vessel occlusion and a large ischemic core at presentation are commonly not considered for mechanical thrombectomy (MT). We tested the hypothesis that in patients with baseline large infarct cores, identification of remaining penumbral tissue using perfusion imaging would translate to better outcomes after MT.

Methods
This was a multicenter, retrospective, core lab adjudicated, cohort study of adult patients with proximal vessel occlusion, a large ischemic core volume (diffusion weighted imaging volume ≥70 mL), with pre-treatment magnetic resonance imaging perfusion, treated with MT (2015 to 2018) or medical care alone (controls; before 2015). Primary outcome measure was 3-month favorable outcome (defined as a modified Rankin Scale of 0–3). Core perfusion mismatch ratio (CPMR) was defined as the volume of critically hypo-perfused tissue (Tmax >6 seconds) divided by the core volume. Multivariable logistic regression models were used to determine factors that were independently associated with clinical outcomes. Outputs are displayed as adjusted odds ratio (aOR) and 95% confidence interval (CI).

Results
A total of 172 patients were included (MT n=130; Control n=42; mean age 69.0±15.4 years; 36% females). Mean core-volume and CPMR were 102.3±36.7 and 1.8±0.7 mL, respectively. As hypothesized, receiving MT was associated with increased probability of favorable outcome and functional independence, as CPMR increased, a difference becoming statistically significant above a mismatch-ratio of 1.72. Similarly, receiving MT was also associated with favorable outcome in the subgroup of 74 patients with CPMR >1.7 (aOR, 8.12; 95% CI, 1.24 to 53.11; P=0.028). Overall (prior to stratification by CPMR) 73 (42.4%) patients had a favorable outcome at 3 months, with no difference amongst groups.

Conclusions
In patients currently deemed ineligible for MT due to large infarct ischemic cores at baseline, CPMR identifies a subgroup strongly benefiting from MT. Prospective studies are warranted.

Keyword

Acute stroke; Ischemic stroke; Thrombectomy; Endovascular treatment; Perfusion imaging
Full Text Links
  • JOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr